TEVA

Teva Pharmaceutical (TEVA) Stock Can Capture 376% Returns

Teva Pharmaceutical is in deep value territory ahead of earnings. This play on TEVA stock is a great alternative to going long outright. More 

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Has 25% Upside

TEVA stock can deliver 25% returns in the next 12 to 18 months on its way towards $40 per share. Here's what you need to know about Teva Pharmaceutical. More 

Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Could Double

If TEVA stock wasn’t so darn low, I’d recommend investors run for the hills. But Teva Pharmaceuticals has some room to run higher. More 

Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Risky

TEVA stock is down 40% over the past year, and trades at low multiples. Is this a good time to buy Teva Pharmaceuticals stock? More 

TEVA Layoffs? Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Denies Job Cut Rumors

Reports claim that a series of TEVA layoffs could cost up to 6,000 employees their jobs, but the company says those numbers are wrong. More 

Why Teva Pharmaceutical Industries Ltd (ADR) Stock Has Staying Power

After a rough few years for TEVA stock, it has become too cheap to ignore. There are risks, but are several reasons to go long Teva Pharma stock. More 

Teva Pharmaceutical Industries Ltd (TEVA) Stock Is a Deep Value Play

Bad PR for TEVA stock will pass, and you'll be happy you bought down in Teva Pharmaceutical here. More